Skip to main content
. Author manuscript; available in PMC: 2011 Dec 10.
Published in final edited form as: Exp Cell Res. 2010 Oct 13;316(20):3478–3488. doi: 10.1016/j.yexcr.2010.09.015

Fig 2. Ciglitazone inhibits the growth of androgen- dependent and – independent human prostate cancer cells.

Fig 2

LNCaP and C4-2 cells were plated in 6 well plates and treated with ciglitazone (0 – 45 μM) for six days. Following treatment, cells were detached using Trypsin- EDTA. Cells were then counted using a Coulter Counter. Each bar represents the mean ± SD for three wells. *, P < 0.05 compared to EtOH control. A representative experiment is shown.